SI-BONE Inc (NASDAQ: SIBN) kicked off on Tuesday, up 5.55% from the previous trading day, before settling in for the closing price of $17.47. Over the past 52 weeks, SIBN has traded in a range of $11.70-$20.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 26.76% over the last five years. While this was happening, its average annual earnings per share was recorded 9.53%. With a float of $36.38 million, this company’s outstanding shares have now reached $41.94 million.
The firm has a total of 344 workers. Let’s measure their productivity. In terms of profitability, gross margin is 77.7%, operating margin of -26.91%, and the pretax margin is -23.82%.
SI-BONE Inc (SIBN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of SI-BONE Inc is 13.26%, while institutional ownership is 90.75%. The most recent insider transaction that took place on Feb 18 ’25, was worth 795,915. In this transaction Chief Executive Officer of this company sold 46,233 shares at a rate of $17.22, taking the stock ownership to the 506,761 shares. Before that another transaction happened on Feb 18 ’25, when Company’s Chief Financial Officer sold 11,180 for $16.86, making the entire transaction worth $188,518. This insider now owns 273,604 shares in total.
SI-BONE Inc (SIBN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.86% during the next five years compared to 13.67% growth over the previous five years of trading.
SI-BONE Inc (NASDAQ: SIBN) Trading Performance Indicators
Take a look at SI-BONE Inc’s (SIBN) current performance indicators. Last quarter, stock had a quick ratio of 6.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.75, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of SI-BONE Inc (SIBN)
Analysing the last 5-days average volume posted by the [SI-BONE Inc, SIBN], we can find that recorded value of 0.7 million was better than the volume posted last year of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 70.20%. Additionally, its Average True Range was 0.88.
During the past 100 days, SI-BONE Inc’s (SIBN) raw stochastic average was set at 90.35%, which indicates a significant increase from 76.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.50% in the past 14 days, which was lower than the 63.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.69, while its 200-day Moving Average is $14.54. Now, the first resistance to watch is $19.17. This is followed by the second major resistance level at $19.90. The third major resistance level sits at $20.63. If the price goes on to break the first support level at $17.70, it is likely to go to the next support level at $16.97. Should the price break the second support level, the third support level stands at $16.24.
SI-BONE Inc (NASDAQ: SIBN) Key Stats
The company with the Market Capitalisation of 773.34 million has total of 41,938K Shares Outstanding. Its annual sales at the moment are 138,890 K in contrast with the sum of -43,340 K annual income. Company’s last quarter sales were recorded 40,340 K and last quarter income was -6,580 K.
